A novel liquid biopsy method can detect kidney cancers with high accuracy, including small, localized tumors which are often curable but for which no early detection method exists.
Tags: cancer health-medicine dana-farber-cancer-institute kidney-cancer biopsy
Scientists produce a reference map of human protein interactions, releasing data helpful for understanding diseases including cancer and infectious diseases such as COVID-19.
Tags: science-technology infectious-diseases cancer covid-19 genes basic-research dana-farber-cancer-institute center-for-cancer-systems-biology human-genome-project human-reference-interactome interactome
Researchers have designed personalized blood biopsies that offer the potential of an early warning signal of breast cancer recurrence.
Tags: science-technology breast-cancer basic-research dana-farber-cancer-institute broad-institute-of-mit-and-harvard blood-biopsies gerstner-center-for-cancer-diagnostics tumor-mutations
Harvard researchers at Dana-Farber Cancer Institute have developed a novel targeted drug that shows promise in advanced kidney cancer by interfering with the abnormal blood vessel formation that fuels tumor growth.
Tags: nobel-prize basic-research health-medicine dana-farber-cancer-institute tumors clear-cell-renal-cell-carcinoma hypoxia-inducible-factor kidney-cancer metastatic-disease mk-6482 phase-iii toni-choueiri william-g-kaelin-jr
A new study from Harvard-affiliated Dana-Farber Cancer Institute finds that non-white minority survivors are less likely than non-Hispanic whites to be seen by cancer specialists who share or understand their culture.
Tags: health-medicine dana-farber-cancer-institute brandon-a-mahal cancer-specialists hispanic minorities non-white santino-s-butler
The first randomized clinical trial of vitamin D in patients with metastatic colorectal cancer found that high doses of supplements combined with chemotherapy delayed disease progression.
Tags: cancer health-medicine dana-farber-cancer-institute vitamin-d delayed-disease-progression metastatic-colorectal-cancer phase-3-trial sunshine-clinical-trial
Study in mice reveals that adult tissues retain a memory of which genes are activated during very early development, and that that memory can be recovered. Under certain conditions, adult cells play their developmental “movie” in a slow rewind, reactivating fetal genes. These findings have important implications for regenerative medicine and cancer research.
Tags: harvard-medical-school health-medicine brigham-and-womens-hospital dana-farber-cancer-institute harvard-stem-cell-institute cell-memory dfci ramesh-shivdasani unmesh-jadhav
Three years after undergoing gene therapy at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center to treat a life-threatening immune disorder, an Ohio college student is no longer thinking about his own “last shot” for health, but rather about medical school and “giving back.”
Tags: health-medicine alvin-powell becky-whittaker boston-childrens-hospital brenden-whittaker cgd chronic-granulomatous-disease clinical-trial dana-farber-cancer-institute dana-farberboston-childrens-cancer-and-blood-disorders-center david-a-williams gene-therapy
Scientists have discovered that irisin, a hormone released by muscles during exercise, directly acts on key regulatory cells that control the breakdown and formation of bone.
Tags: exercise health-medicine dana-farber-cancer-institute bone-thinning bruce-spiegelman irisin osteocytes osteoporosis
Harvard researchers have identified in mice a set of neurons responsible for sustained pain and pain-coping behaviors. The new study is the first one to map out how these responses arise outside the brain.
Tags: brain harvard-medical-school neurons health-medicine dana-farber-cancer-institute blavatnik-institute-at-harvard-medical-school ekaterina-pesheva pain qiufu-ma signaling-pathways
Page 1 of 1